Tirzepatide 5mg

Tirzepatide is a dual GLP-1/GIP receptor agonist peptide that simultaneously activates both glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptors. This dual-target mechanism has made it a compound of significant interest in metabolic research, particularly in studies exploring glucose-dependent insulin secretion, appetite regulation, and energy homeostasis. The dual agonist approach represents a distinct pharmacological strategy from single-receptor agonists.

As a research-grade reference material, our Tirzepatide is supplied as a lyophilized powder with a purity of ≥99.1% as verified by HPLC and mass spectrometry. Each batch is accompanied by a Certificate of Analysis documenting sequence integrity, molecular weight confirmation, and chromatographic purity. Researchers investigating dual agonist mechanisms in metabolic models require consistent, high-purity compounds with documented analytical credentials.

Our UK-based supply chain ensures rapid dispatch and tracked delivery from synthesis to your laboratory, minimising transit time for temperature-sensitive materials.